Tirzepatide Superior to Semaglutide in T2D Therapy Targets
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
Related Articles
EFSD and Lilly European Diabetes Research Programme | EFSD
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives…
Diabetes Medical Management Plan | American Diabetes Association
Ensure standardized and efficient diabetes care in schools with our updated DMMP form. Tailor care instructions for individual students, providing clarity for caregivers.
The role of ultra-processed food in obesity
Nature Reviews Endocrinology – Consumption of ultra-processed foods (UPF) is increasingly linked to the development of obesity, on both an individual and a global scale.…
Bile acids in the crosshairs for hypoglycaemia after gastric bypass
Nature Reviews Endocrinology – Bile acids are increasingly recognized for their broad metabolic effects, including the regulation of glucose homeostasis. In a recent study published…
The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus
Nature Reviews Endocrinology – Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline…
ESE Talks… Balancing the demands of work and family life. Led by EUWIN. | ESE
Following the success of our previous European Women in Endocrinology (EUWIN) led events, our panel will bring their own personal experiences and guidance to this…
Obesity as a disease | World Obesity Federation
REFERENCES World Health Organization, 1999. Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series 894, Geneva: World Health Organization. Kopelman PG, Finer N.…
Crenessity benefits continue for adults, children with congenital adrenal hyperplasia
SAN FRANCISCO — Adults with congenital adrenal hyperplasia treated with an oral nonsteroidal drug saw continued disease control with reduced daily glucocorticoid doses and other…
Obesity drugs may raise testosterone in men
SAN FRANCISCO — Incretin-based drugs, such as semaglutide and tirzepatide, are tied to increases in total testosterone and free testosterone for men, researchers reported at…
Beyond a singular focus on GLP-1: why we need a new nomenclature now
The development of glucagon-like peptide-1 (GLP-1)-based therapies for type 2 diabetes and obesity illustrates a remarkable evolution in scientific understanding and therapeutic innovation.1 As the…
